Intellia Therapeutics Revenue Misses Estimates as GAAP Loss Per Share Hits $0.91

Total revenue was $7.16 million, $2.61 million below estimates. Collaboration revenue fell 48% year over year to $7.2 million.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.